Dow Up0.08% Nasdaq Down0.30%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.33 0.00(0.00%) 4:00PM EDT
|After Hours : 1.33 0.00 (0.00%) 4:05PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 1,075   752   535   400  
Cost of Revenue270  193  152  75  
Gross Profit 804   559   383   325  
Operating Expenses
Research Development5,112  5,227  9,415  6,278  
Selling General and Administrative4,908  3,911  4,021  3,971  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (9,216) (8,579) (13,053) (9,925)
Income from Continuing Operations
Total Other Income/Expenses Net(93)(2,218)275  (405)
Earnings Before Interest And Taxes(6,698)(10,797)(14,150)(10,330)
Interest Expense914  944  974  976  
Income Before Tax(7,612)(11,741)(15,124)(11,306)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(7,612)(14,351)(13,752)(11,306)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (7,612) (14,351) (13,752) (11,306)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (10,222) (11,741) (13,752) (11,306)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.